Selection criteria for liver transplantation in patients with hepatocellular carcinoma: Beyond tumor size and number?

Liver Transplantation

Volumn 12, Issue 8, 2006, Pages 1189-1191

  Yao, Francis Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; EDITORIAL; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RECURRENCE RISK; RELIABILITY; RESEARCH ETHICS; RESOURCE ALLOCATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TUMOR VOLUME; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; TISSUE DONORS;

EID: 33746930663     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20853     Document Type: Editorial

References (18)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001:33:1394-1403.
3. United Network for Organ Sharing, Policy 3.6. Available at: http:// www.unos.org/policiesandbylaws/policies.asp?resources=true. Accessed: April 18, 2006.
4. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127(suppl):S261-267.
5. Kirmlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, et al. Hepatocellular carcinoma in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implication. Hepatology 2001;34:502-510.
6. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004:10:36-41.
7. Di Bisceglie AM, Carithers RL, Gores GJ. Hepatocellular carcinoma. Hepatology 1998;28:1161-1165.
8. Otto G, Herber S, Heise M, Lohse AW, Monch C, Bittinger F, et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006;12:1260-1267.
9. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
10. Marsh JW, Finkelstein SD, Demetris AJ, Swalsky PA, Sasatomi E, Bandos A, et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl 2003;9:664-671.
11. Jonas S, Bechstein WO, Steinmuller T, Herrman M, Radke C, Berg T, et al. Vascular invasion and histologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33: 1080-1086.
12. Hemming AW, Cattral MS, Reed AI, Van der Warf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659.
13. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, et al. Liver transplantation for the treatment of moderately or well differentiated hepatocellular carcinoma. Ann Surg 2004;239:150-159.
14. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Mg IOL, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086-1092.
15. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701.
16. Yao FY, Hirose R, LaBerge J, Davern T II, Bass NM, Kerlan R, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514.
17. Yao FY, Kinkhabwala M, LaBerge J, Bass NM, Brown R, Kerlan R, et al. The impact of pre-operative loco-regional treatments on survival following liver transplantation for hepatocellular carcinoma. Am J Transpl 2005;5:795-804.
18. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 2002;235:533-539.